Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders
Open Access
- 9 June 2010
- journal article
- research article
- Published by Springer Nature in Journal of Gastroenterology
- Vol. 45 (11) , 1163-1171
Abstract
Iron overload syndromes include a wide spectrum of genetic and acquired conditions. Recent studies suggest suppressed hepcidin synthesis in the liver to be the molecular basis of hemochromatosis. However, a liver with acquired iron overload synthesizes an adequate amount of hepcidin. Thus, hepcidin could function as a biochemical marker for differential diagnosis of iron overload syndromes.Keywords
This publication has 51 references indexed in Scilit:
- Reduced serum hepcidin levels in patients with chronic hepatitis CJournal of Hepatology, 2009
- Serum hepcidin levels are innately low in HFE‐related haemochromatosis but differ between C282Y‐homozygotes with elevated and normal ferritin levelsBritish Journal of Haematology, 2008
- Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI‐ceruloplasminThe EMBO Journal, 2007
- Suppression of hepcidin during anemia requires erythropoietic activityBlood, 2006
- Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its InternalizationScience, 2004
- Iron chelation therapy in aceruloplasminaemia: study of a patient with a novel missense mutationGut, 2004
- Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase proteinBlood, 2003
- Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosisNature Genetics, 2002
- A New Mouse Liver-specific Gene, Encoding a Protein Homologous to Human Antimicrobial Peptide Hepcidin, Is Overexpressed during Iron OverloadJournal of Biological Chemistry, 2001
- Hepcidin, a Urinary Antimicrobial Peptide Synthesized in the LiverJournal of Biological Chemistry, 2001